张长弓 - Chinese Academy of Medical Sciences, Peking Union Medical College

基本信息

浏览量：95

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 88 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Clinical Features, Prognostic Stratification, and Treatment of Advanced-Stage Non-Nasal Type Extranodal Natural Killer/t-Cell Lymphoma: a Multi-Institutional Real-World Study

Yu-Ce Wei,Wei-Xin Liu,Fei Qi,Chang-Gong Zhang,Bao-Min Zheng,Yan Xie,Bo Chen,Di Zhang,Wei-Ping Liu,Hui Fang,Yue Chai,Shu-Nan Qi,Ye-Xiong Li,Wei-Hu Wang,Yu-Qin Song,Jun Zhu,Mei Dong

ANNALS OF HEMATOLOGYno. 1 (2024): 163-174

引用1浏览0WOS引用

Efficacy and Safety of Anlotinib Plus Penpulimab As Second-Line Treatment for Small Cell Lung Cancer: A Multicenter, Open-Label, Single-Arm Phase II Trial

Changgong Zhang,Jianhua Chen,Huijuan Wu,Jun Wang,Liying Gao,Jun Zhao,Yan Sun,Zhongyao Jia,Xinlin Mu,Chunmei Bai,Rui Wang,Kailiang Wu, Qiang Liu,Yuankai Shi

Cancer Pathogenesis and Therapy (2024)

引用1浏览0WOS引用

Efficacy, Safety, and Multi-Omics Analysis of Pembrolizumab Combined with Nab-Paclitaxel and Platinum As First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Study

Lin Gui,Xinrui Chen,Wen Zhang,Zucheng Xie,Yu Zhang,Weihua Li,Tongji Xie,Jiarui Yao,Haohua Zhu,Le Tang,Jianliang Yang,Peng Liu,Yan Qin,Changgong Zhang,Xiaohui He,Yuankai Shi

CHINESE JOURNAL OF CANCER RESEARCHno. 6 (2024)

引用0浏览0WOS引用

Low-dose Pegylated Recombinant Human Granulocyte-Colony Stimulating Factor As Hematopoietic Support for Adjuvant Chemotherapy in Chinese Patients with Breast Cancer: an Open-Label, Randomized, Non-Inferiority Trial

Sheng Yang,Shan-shan Chen,Chang-gong Zhang, Ying-lei Zhou,Meng Xiu,Pin Zhang

British Journal of Clinical Pharmacology（2024）

引用0浏览0WOS引用

Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes

Zucheng Xie,Yan Qin,Xinrui Chen,Sheng Yang,Jianliang Yang,Lin Gui,Peng Liu,Xiaohui He,Shengyu Zhou,Changgong Zhang,Le Tang,Yuankai Shi

TARGETED ONCOLOGYno. 3 (2024): 383-400

引用1浏览0WOS引用

Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study Across Two Decades

Yu-Ce Wei,Fei Qi, Bo Chen,Chang-Gong Zhang,Hui Fang,Di Zhang,Shu-Nan Qi,Yue Chai,Ye-Xiong Li,Mei Dong

Chemotherapy（2023）

引用0浏览0WOS引用

The Clinical Features, Treatment, and Prognostic Factors for Peripheral T-cell Lymphomas: A Single-Institution Analysis of 240 Chinese Patients

Haizhu Chen,Yunxia Tao, Yu Zhou,Peng Liu,Jianliang Yang,Xiaohui He,Shengyu Zhou,Yan Qin,Yongwen Song,Lin Gui,Changgong Zhang,Sheng Yang,Yuankai Shi

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2023）

引用3浏览0WOS引用

A Phase II Study Cohort of Penpulimab Plus Anlotinib in Patients with Recurrent or Metastatic Non-Squamous Cell Carcinomas of Head and Neck

Changgong Zhang,Yan Sun,Jun Wang,Zhigang Liu,Haichuan Su,Jianhua Chen,Youxin Tian,Huijuan Wu,Liying Gao,Yuankai Shi

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Clinical Characteristics and Treatment Outcomes of Chinese Diffuse Large B-cell Lymphoma Patients in the Era of Rituximab (2005–2018)

Yuankai Shi,Haizhu Chen,Yan Qin,Jianliang Yang,Peng Liu,Xiaohui He,Shengyu Zhou,Liqiang Zhou,Changgong Zhang,Yongwen Song,Yueping Liu,Lin Gui,Shulian Wang,Jing Jin, Hui Fang,Shunan Qi,Ning Li, Yu Tang, Xin Wang,Sheng Yang

CANCER PATHOGENESIS AND THERAPYno. 1 (2023): 3-11

引用5浏览0WOS引用

MYD88L265P and MYD88other Variants Show Different Molecular Characteristics and Prognostic Significance in Diffuse Large B-cell Lymphoma

Yan Qin,Tian Qiu,Zucheng Xie,Xinrui Chen,Peng Liu,Jianliang Yang,Xiaohui He,Lin Gui,Shengyu Zhou,Hongxin Jiang,Changgong Zhang,Sheng Yang,Le Tang,Yuankai Shi

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY（2023）

引用5浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Chang-Gong Zhang(张长弓)

论文共 88 篇作者统计合作学者相似作者